Cytokine and chemokine levels in coronavirus disease 2019 convalescent plasma
Background The efficacy of coronavirus disease 2019 (COVID-19) convalescent plasma
(CCP) is primarily ascribed as a source of neutralizing anti-severe acute respiratory …
(CCP) is primarily ascribed as a source of neutralizing anti-severe acute respiratory …
[HTML][HTML] Cytokine and Chemokine Levels in Coronavirus Disease 2019 Convalescent Plasma
TS Bonny, EU Patel, X Zhu, EM Bloch… - Open Forum …, 2021 - ncbi.nlm.nih.gov
Background The efficacy of coronavirus disease 2019 (COVID-19) convalescent plasma
(CCP) is primarily ascribed as a source of neutralizing anti-severe acute respiratory …
(CCP) is primarily ascribed as a source of neutralizing anti-severe acute respiratory …
[PDF][PDF] Cytokine and Chemokine Levels in Coronavirus Disease 2019 Convalescent Plasma
TS Bonny, EU Patel, X Zhu, EM Bloch, MK Grabowski… - 2020 - pdfs.semanticscholar.org
Background. The efficacy of coronavirus disease 2019 (COVID-19) convalescent plasma
(CCP) is primarily ascribed as a source of neutralizing anti-severe acute respiratory …
(CCP) is primarily ascribed as a source of neutralizing anti-severe acute respiratory …
Cytokine and Chemokine Levels in Coronavirus Disease 2019 Convalescent Plasma.
TS Bonny, EU Patel, X Zhu, EM Bloch… - Open Forum …, 2020 - europepmc.org
Background The efficacy of coronavirus disease 2019 (COVID-19) convalescent plasma
(CCP) is primarily ascribed as a source of neutralizing anti-severe acute respiratory …
(CCP) is primarily ascribed as a source of neutralizing anti-severe acute respiratory …
[PDF][PDF] Cytokine and Chemokine Levels in Coronavirus Disease 2019 Convalescent Plasma
TS Bonny, EU Patel, X Zhu, EM Bloch… - Open Forum …, 2021 - academic.oup.com
Background The efficacy of coronavirus disease 2019 (COVID-19) convalescent plasma
(CCP) is primarily ascribed as a source of neutralizing anti-severe acute respiratory …
(CCP) is primarily ascribed as a source of neutralizing anti-severe acute respiratory …
Cytokine and Chemokine Levels in Coronavirus Disease 2019 Convalescent Plasma
TS Bonny, EU Patel, X Zhu, EM Bloch… - Open Forum Infectious …, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Background</jats: title>< jats: p>
The efficacy of coronavirus disease 2019 (COVID-19) convalescent plasma (CCP) is …
The efficacy of coronavirus disease 2019 (COVID-19) convalescent plasma (CCP) is …
Cytokine and Chemokine Levels in Coronavirus Disease 2019 Convalescent Plasma
TS Bonny, EU Patel, X Zhu… - Open forum …, 2020 - pubmed.ncbi.nlm.nih.gov
Background The efficacy of coronavirus disease 2019 (COVID-19) convalescent plasma
(CCP) is primarily ascribed as a source of neutralizing anti-severe acute respiratory …
(CCP) is primarily ascribed as a source of neutralizing anti-severe acute respiratory …
Cytokine and Chemokine Levels in Coronavirus Disease 2019 Convalescent Plasma.
TS Bonny, EU Patel, X Zhu, EM Bloch… - Open Forum …, 2021 - search.ebscohost.com
Background The efficacy of coronavirus disease 2019 (COVID-19) convalescent plasma
(CCP) is primarily ascribed as a source of neutralizing anti-severe acute respiratory …
(CCP) is primarily ascribed as a source of neutralizing anti-severe acute respiratory …
[PDF][PDF] Cytokine and Chemokine Levels in COVID-19 Convalescent Plasma
TS Bonny, EU Patel, X Zhu, EM Bloch, MK Grabowski… - 2020 - scienceopen.com
Background The efficacy of COVID-19 convalescent plasma (CCP) is primarily ascribed as a
source of neutralizing anti-SARS-CoV-2 antibodies. However, the composition of other …
source of neutralizing anti-SARS-CoV-2 antibodies. However, the composition of other …
Cytokine and Chemokine Levels in Coronavirus Disease 2019 Convalescent Plasma
TS Bonny, EU Patel, X Zhu, EM Bloch… - Open Forum …, 2021 - pure.johnshopkins.edu
Background: The efficacy of coronavirus disease 2019 (COVID-19) convalescent plasma
(CCP) is primarily ascribed as a source of neutralizing anti-severe acute respiratory …
(CCP) is primarily ascribed as a source of neutralizing anti-severe acute respiratory …